Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Systemic therapeutic options in thymic malignancies: a glimmer of hope.

Hammond-Thelin LA, Thomas CR Jr.

Rev Recent Clin Trials. 2007 Sep;2(3):191-205. Review.

PMID:
18474005
[PubMed - indexed for MEDLINE]
2.

Current chemotherapy options for thymic epithelial neoplasms.

Papadopoulos KP, Thomas CR Jr.

Expert Opin Pharmacother. 2005 Jun;6(7):1169-77. Review.

PMID:
15957970
[PubMed - indexed for MEDLINE]
3.

Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report.

Li XF, Chen Q, Huang WX, Ye YB.

Med Oncol. 2009;26(2):157-60. doi: 10.1007/s12032-008-9100-0. Epub 2008 Oct 10.

PMID:
18846437
[PubMed - indexed for MEDLINE]
4.

Targeted therapies for thymic malignancies.

Girard N.

Thorac Surg Clin. 2011 Feb;21(1):115-23, viii. doi: 10.1016/j.thorsurg.2010.08.004. Review.

PMID:
21070993
[PubMed - indexed for MEDLINE]
5.

Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.

Surakanti SG, Agulnik M.

Semin Oncol. 2008 Jun;35(3):309-19. doi: 10.1053/j.seminoncol.2008.03.009. Review.

PMID:
18544445
[PubMed - indexed for MEDLINE]
6.

Therapeutic potential of novel selective-spectrum kinase inhibitors in oncology.

Lorusso PM, Eder JP.

Expert Opin Investig Drugs. 2008 Jul;17(7):1013-28. doi: 10.1517/13543784.17.7.1013 . Review.

PMID:
18549338
[PubMed - indexed for MEDLINE]
7.

New drugs in acute myeloid leukemia.

Grever MR.

Clin Adv Hematol Oncol. 2003 Aug;1(8):456-9. Review. No abstract available.

PMID:
16258431
[PubMed - indexed for MEDLINE]
8.

Novel targeted radiosensitisers in cancer treatment.

Zaidi SH, Huddart RA, Harrington KJ.

Curr Drug Discov Technol. 2009 Jun;6(2):103-34. Review.

PMID:
19519337
[PubMed - indexed for MEDLINE]
9.

Targeted therapy for advanced thymic tumors.

Rajan A, Giaccone G.

J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S361-4. doi: 10.1097/JTO.0b013e3181f21114. Review.

PMID:
20859134
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.

Byrd JC, Grever MR, Waselenko JK, Willis CR, Park K, Goodrich A, Lucas MA, Shinn C, Flinn IW.

Semin Oncol. 2000 Apr;27(2 Suppl 5):37-40.

PMID:
10877050
[PubMed - indexed for MEDLINE]
11.

Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.

Tortora G, Ciardiello F, Gasparini G.

Nat Clin Pract Oncol. 2008 Sep;5(9):521-30. doi: 10.1038/ncponc1161. Epub 2008 Jul 1. Review.

PMID:
18594498
[PubMed - indexed for MEDLINE]
12.

Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.

Medina PJ, Goodin S.

Clin Ther. 2008 Aug;30(8):1426-47. doi: 10.1016/j.clinthera.2008.08.008. Review.

PMID:
18803986
[PubMed - indexed for MEDLINE]
13.

Targeted therapies in head and neck cancer: past, present and future.

Rapidis AD, Vermorken JB, Bourhis J.

Rev Recent Clin Trials. 2008 Sep;3(3):156-66. Review.

PMID:
18782074
[PubMed - indexed for MEDLINE]
14.

The role of chemotherapy in advanced thymoma.

Schmitt J, Loehrer PJ Sr.

J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S357-60. doi: 10.1097/JTO.0b013e3181f21129. Review.

PMID:
20859133
[PubMed - indexed for MEDLINE]
15.

Standards and novel therapeutic options in the treatment of patients with soft tissue sarcoma.

Kasper B.

Rev Recent Clin Trials. 2007 Sep;2(3):206-11. Review.

PMID:
18474006
[PubMed - indexed for MEDLINE]
16.

Thymic malignancies: from clinical management to targeted therapies.

Kelly RJ, Petrini I, Rajan A, Wang Y, Giaccone G.

J Clin Oncol. 2011 Dec 20;29(36):4820-7. doi: 10.1200/JCO.2011.36.0487. Epub 2011 Nov 21. Review.

PMID:
22105817
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Management of small-cell lung cancer: incremental changes but hope for the future.

Hann CL, Rudin CM.

Oncology (Williston Park). 2008 Nov 30;22(13):1486-92. Review.

PMID:
19133604
[PubMed - indexed for MEDLINE]
19.

Neuroendocrine tumors: novel approaches in the age of targeted therapy.

Phan AT, Yao JC.

Oncology (Williston Park). 2008 Dec;22(14):1617-23; discussion 1623-4, 1629.

PMID:
19198220
[PubMed - indexed for MEDLINE]
20.

Esophageal cancer: current and emerging therapy modalities.

Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M, Bergqvist M.

Expert Rev Anticancer Ther. 2008 Sep;8(9):1433-48. doi: 10.1586/14737140.8.9.1433. Review.

PMID:
18759695
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk